Epitalon
Epithalon (Epithalamin Tetrapeptide)
Evidence & Status
- Preliminary / Experimental
- Preliminary
At a Glance
A synthetic tetrapeptide originally derived from a bovine pineal gland extract, studied for its potential connections to telomere biology, antioxidant activity, and age-related changes in the pineal gland. The majority of research was conducted by Russian scientists over several decades.
Plain English
Researchers study Epitalon because it may play a role in how cells age at a molecular level. Scientists are particularly interested in its potential connections to telomeres — the protective end-caps on chromosomes that tend to shorten as cells divide over a lifetime — and whether it can influence the activity of an enzyme called telomerase, which helps maintain telomere length. Researchers have also studied its potential role in supporting melatonin production in aging individuals, since the pineal gland's output naturally declines with age. The bulk of available research was conducted by Russian scientists, with limited large-scale human trial data available outside those studies.
Overview
A synthetic tetrapeptide derived from the natural bovine pineal gland extract epithalamin. In cell-based research, Epithalon has been shown to induce telomerase activity and telomere elongation in human somatic cells. Studied by Vladimir Khavinson's group at the Saint Petersburg Institute of Bioregulation and Gerontology for potential anti-aging applications. Additional claims regarding melatonin normalization, lifespan extension, and reduced tumor incidence appear in the broader literature, but the source identifiers previously associated with those claims in this record could not be verified as correct entities and have been removed. Human clinical data are limited.
Research Summary
Epitalon has been studied primarily by Vladimir Khavinson's group at the Saint Petersburg Institute of Bioregulation and Gerontology. A verified in-vitro study (Khavinson et al., 2003) demonstrated telomerase activation and telomere elongation in human somatic cells — this is the primary verified mechanistic finding in this record. Claims regarding lifespan extension in aged rodents, melatonin normalization in aging pineal glands, and reduced tumor incidence were previously cited in this record, but the associated PubMed identifiers could not be verified as correct entities and have been removed. Small human observational studies have been published within the Khavinson group, but source identifiers for those studies are not verified in this record. Independent replication by groups outside the Khavinson laboratory is very limited. Overall evidence remains preliminary.
Research Areas
- Telomere biology & elongation
- Anti-aging
- Melatonin regulation
- Antioxidant
- Cancer prevention (animal models)
Safety & Risks
Serious Risks
- Insufficient long-term human safety data; theoretical concern regarding telomerase activation and cancer cell proliferation
Reported Side Effects
- Generally well-tolerated; occasional injection site redness
- Mild fatigue (transient)
Legal Status by Region
- United States
- Research only
- United Kingdom
- Research only
- Australia
- Research only
- Canada
- Research only
Citations & Sources
- Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells
Khavinson VKh, Bondarev IE, Butyugov AA · Bulletin of Experimental Biology and Medicine · 2003
PMID 12937682